(d) Antiallergy agents.
1. Topical and oral antihistamine agents in the following drug categories.
b. Ethanolamines
c. Ethylenediamines.
d. Phenothiazines.
e. Piperazines.
f. Piperidines.
g. Terfenadines.
2. Cromolyn sodium, a mast cell stabilizing agent.
(e) Artificial tear solutions, ophthalmic irrigants and ocular lubricants.
(f) Hypertonic sodium chloride, a topical hyperosmotic agent.
(g) Yellow mercuric oxide, a miscellaneous preparation and product.
(h) Topical anesthetics.
1. Benoxinate HCl.
2. Benoxinate HCl and sodium fluorescein.
3. Proparacaine HCl.
4. Tetracaine HCl.
(i) Antibiotics.
1. Topical antibiotics.
a. Aminoglycosides.
b. Bacitracin.
c. Cephalosporins.
d. Ciprofloxacin HCl.
e. Erythromycin.
f. Gramicidin.
g. Norfloxacin
h. Penicillins.
i. Polymyxin B.
j. Sulfonamides.
k. Tetracyclines.
L. Trimethoprim.
m. Zinc sulfate.
2. Oral antibiotics.
a. Erythromycin.
b. Tetracycline.
3. Topical antiviral agents.
a. Acyclovir.
b. Idoxuridine.
c. Trifluridine.
d. Vidarabine.
4. Acyclovir, an oral antiviral agent.
(j) Anti-inflammatory agents.
1. Oral non-steroidal anti-inflammatory agents.
a. Fenoprofen.
b. Ibuprofen.
c. Ketoprofen.
d. Naproxen.
2. Topical corticosteroid agents.
a. Dexamethasone.
b. Fluoromethalone.
c. Medrysone.
d. Prednisolone.
e. Prednisolone and atropine combinations.
f. Topical corticosteroid and antibiotic combinations.
g. Topical corticosteroid and mydriatic combinations.
3. Topical non-steroidal agent, diclofenac sodium.
(k) Topical anticholinergic agents.
1. Atropine.
2. Atropine sulfate.
3. Cyclopentolate.
4. Homatropine.
5. Homatropine hydrogen bromide.
6. Scopolamine.
7. Tropicamide.
(L) Antiglaucomatous agents.
1. Sympathomimetics.
a. Dipivefrin.
b. Epinephrine.
2. Miotics, direct acting.
a. Acetylcholine.
b. Carbachol.
c. Pilocarpine.
3. Miotics, cholinesterase inhibitors.
b. Echothiophate.
c. Isoflurophate.
d. Physostigmine.
4. Topical beta-adrenergic blocking agents.
a. Betaxolol.
b. Carteolol HCl.
c. Levobunolol.
d. Metipranolol HCl.
e. Timolol.
5. Oral carbonic anhydrase inhibitors.
a. Acetazolamide.
b. Dichlorphenamide.
c. Methazolamide.
(m) Any drug or device that is used for an ophthalmic therapeutic purpose and that is the subject of a new drug application approved by the food and drug administration under section 505 (c) (1) of the federal food, drug and cosmetic act, 21 USC 355, as amended.
